St. Louis, MO, United States of America

Jorn C Albring

This inventor holds 2 USPTO granted patents. Top assignee: Washington University. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jorn C Albring. Retrieved from https://idiyas.com/inventor/jorn-c-albring

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jorn C Albring: Innovator in Inducing In Vivo Tolerance

Introduction

Jorn C Albring is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of biomedical research, particularly in methods for inducing in vivo tolerance to foreign tissues. With a total of 2 patents, his work has the potential to impact transplant medicine and immunology.

Latest Patents

Albring's latest patents focus on innovative methods for inducing in vivo tolerance. The present invention encompasses techniques that aim to promote acceptance of foreign tissues within the body, which is crucial for successful organ transplants and reducing the risk of rejection.

Career Highlights

Jorn C Albring is affiliated with Washington University, where he conducts his research. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations

Albring collaborates with esteemed colleagues, including Michelle M Sandau and Kenneth M Murphy. These partnerships enhance the research environment and foster the development of groundbreaking ideas.

Conclusion

Jorn C Albring is a distinguished inventor whose work in inducing in vivo tolerance is paving the way for advancements in transplant medicine. His contributions are vital to the ongoing evolution of biomedical research and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…